Prophylactic treatment with trimethoprim-sulfamethoxazole (TMP-SMX) significantly reduced the risk for serious infections by approximately 50% in patients with antineutrophil cytoplasmic antibody ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback